Diagnostics (Mar 2024)

A Comparative Evaluation of Multiparametric Magnetic Resonance Imaging and Micro-Ultrasound for the Detection of Clinically Significant Prostate Cancer in Patients with Prior Negative Biopsies

  • Edoardo Beatrici,
  • Nicola Frego,
  • Giuseppe Chiarelli,
  • Federica Sordelli,
  • Stefano Mancon,
  • Cesare Saitta,
  • Fabio De Carne,
  • Giuseppe Garofano,
  • Paola Arena,
  • Pier Paolo Avolio,
  • Andrea Gobbo,
  • Alessandro Uleri,
  • Roberto Contieri,
  • Marco Paciotti,
  • Massimo Lazzeri,
  • Rodolfo Hurle,
  • Paolo Casale,
  • Nicolò Maria Buffi,
  • Giovanni Lughezzani

DOI
https://doi.org/10.3390/diagnostics14050525
Journal volume & issue
Vol. 14, no. 5
p. 525

Abstract

Read online

Background: The diagnostic process for prostate cancer after a negative biopsy is challenging. This study compares the diagnostic accuracy of micro-ultrasound (mUS) with multiparametric magnetic resonance imaging (mpMRI) for such cases. Methods: A retrospective cohort study was performed, targeting men with previous negative biopsies and using mUS and mpMRI to detect prostate cancer and clinically significant prostate cancer (csPCa). Results: In our cohort of 1397 men, 304 had a history of negative biopsies. mUS was more sensitive than mpMRI, with better predictive value for negative results. Importantly, mUS was significantly associated with csPCa detection (adjusted odds ratio [aOR]: 6.58; 95% confidence interval [CI]: 1.15–37.8; p = 0.035). Conclusions: mUS may be preferable for diagnosing prostate cancer in previously biopsy-negative patients. However, the retrospective design of this study at a single institution suggests that further research across multiple centers is warranted.

Keywords